Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 50

Boehringer Ingelheim regenerates Agomab

Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer spun out of University of Turin.

Apr 16, 2019

Inozyme hardens up with $67m

Novo and Sanofi Ventures returned to reinvest in Yale spinout Inozyme Pharma as it looks to advance its lead mineralisation disorder drug towards the clinic.

Apr 11, 2019

Vector delivers $10m series A

Vector has received funding from UC-backed Congruent Ventures among others as it looks to enhance its software in supporting back office logistics functions.

Apr 10, 2019

Deep Lens recruits $14m

Nationwide Children’s-founded advanced pathology platform Deep Lens has now raised $17.5m in all as it looks to grow its business in the clinical trial recruitment segment.

Apr 9, 2019

Deal net: 1 – 5 April 2019

The Global University Venturing Deal Net rounds up the week’s smaller deals and tracks the startups emerging from universities and raising funding.

Apr 5, 2019

Hungry devours $8m

Catering services marketplace Hungry has now raised $12.5m in total, having added university venture unit James Madison Innovations to its investment consortium.

Apr 5, 2019

Mints chips in to $6m Movellus round

University of Michigan’s Mints vehicle joined existing investor Intel Capital for SOC producer Movellus’ series A round, which increased the company's overall funding to $10m.

Apr 3, 2019

NextGen Jane nets $9m in series A funding

NextGen Jane, which is looking to commercialise reproductive health technology partially developed at Harvard, has received $9m from investors including Harvard-affiliated backers.

Apr 3, 2019

Fifth Eye channels $11.5m

University of Michigan critical care monitoring technology spinout Fifth Eye has collected series A funding from investors including the university's Mints fund.

Apr 2, 2019

Kyoto aligns itself with AlphaNavi's series A

Kyoto University has taken part in an $8.1m series A round for Alphanavi Pharma, which is developing drugs for neuropathic pain that will partly be based on the institution's research.

Apr 1, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here